Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0000875320-24-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-27 | 2024-02-23 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $431.79 | -2,469 | 58.3K | -4% | -$1.07M | |
| 2024-02-27 | 2024-02-26 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $425.70 | -3,004 | 55.3K | -5% | -$1.28M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | F | D | 2,469 | $431.79 | 58,329 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-26 | S | D | 3,004 | $425.70 | 55,325 | D | — | — |